Posts

September 14, 2014

+
10:00 AM | Blogging for a science magazine
A Q&A What is it like to blog for a science magazine? Is it different from blogging on your own independent WordPress or BlogSpot platform? What's it like to have a blog editor? Do blogs change as they are moved from independent websites to magazine blog networks? These are some of the questions I've been wondering about as I interview science bloggers for my PhD project (#MySciBlog), because science bloggers fill such a variety of roles for a variety of... Read more
+
8:58 AM | Idrogeno a bassa tensione: nuove sfide della ricerca
Che scoperta mai sarebbe la produzione di idrogeno a partire da una pila? È un esperimento che chiunque potrebbe fare a casa propria con una pila, ripescando le spiegazioni del professore di chimica delle scuole superiori. Eppure la scoperta della Stanford non…Read more →

September 13, 2014

+
7:58 PM | Success and Failure of Anti-Vaccine Legislative Efforts, 1998-2012
This article was written by Dorit Rubinstein Reiss, Professor of Law at the University of California Hastings College of the Law in San Francisco, CA. She has written a valuable review of the recently published article, “Power and Persuasion in the Vaccine Debates: An Analysis of Political Efforts and Outcomes in the United States, 1998-2012”. Dr. Reiss writes extensively in law journals about […]Continue reading «Success and […]
+
3:11 PM | Una supernova per Gaia
Individuata in una galassia a mezzo miliardo di anni luce dalla Terra, si sospetta che possa essere un’esplosione di tipo Ia. Antonella Vallenari (INAF): «Un risultato che conferma l’eccellente qualità dei dati e l’enorme potenziale scientifico della missione»Read more →
+
2:52 PM | Mibact E Promo Pa Fondazione A Lubec Premiano Le Idee Under 40!
Aperte Le Iscrizioni A Creathon La Maratona Per Fabbricatori Digitali Under 40 Sul Tema Cultura E Turismo. Premi per i primi tre team classificati Read more →
+
2:48 PM | Continuano Le Adesioni Alla Settimana Europea Per La Riduzione Dei Rifiuti 2014
Venerdì 10 ottobre: è questo il termine ultimo per poter aderire alla Sesta edizione della Settimana Europea per la Riduzione dei Rifiuti, che si terrà dal 22 al 30 novembre 2014. Lo ha annunciato il Comitato promotore nazionale, di cui…Read more →
+
2:46 PM | Al via il Comitato Scientifico per la Prevenzione dei Rifiuti Galletti: Evitare lo spreco alimentare anche missione etica
Al Ministero dell’Ambiente si è svolta la prima riunione dell’organismo presieduto da Andrea Segrè con la vicepresidenza Roberto CavalloRead more →
+
12:55 PM | CDRH: Women Underrepresented In Medical Device Trials
Clinical trials are the backbone from which medical device manufacturers draw the data required to determine whether a new product is both safe and effective. A recent post from the FDA’s official blog – the FDA Voice – has pointed out that there exists a significant highlighted the gap between the patient populations used to ... continue reading
+
4:00 AM | Black Pee Disease Offers New View of Arthritic Joints
When I read the headline of a recent press release – "A new cause of osteoarthritis identified by research on a rare disease" -- I was drawn to "rare disease," even though I actually have osteoarthritis. And when I read “alkaptonuria," I was catapulted back more than a century to the first description of an "inborn error of metabolism.”

September 12, 2014

+
6:24 PM | One mother’s crusade against antibiotics–it’s complicated
This is a guest post by Karen Ernst, who is the parent-leader of Voices for Vaccines, a parent-led organization that supports and advocates for on-time vaccination and the reduction of vaccine-preventable disease. Karen is the mother of three boys and the wife of a military officer, living in Minnesota.  I could be the mother-in-charge of the such the […]Continue reading «One mother's crusade against antibiotics–it's complicated»
+
6:09 PM | Back to School Biotech Reading List
Genetics and decision-making in drug discovery Part 1: overview ANDDecision-making part 2: Genetics and assays for drug discoveryRobert Plenge (Plenge Lab blog)Biotech's recent examples of why turnover can be an ominous signBrad Loncar (Loncar blog) $ACRX $KINMaking clinical development more investable with “financially adaptive trials”Frank David (Pharmagellan)The Transformation: Is it possible to control cancer without killing it?Jerome Groopman (The New Yorker) […]
+
2:44 PM | How could I build a flying bicycle?
On a sunny afternoon in July of 2008, I decided to join other residents of Tang Hall to a building barbecue. This seemed like a great opportunity to get some free food and meet some interesting people. But it was far more than that. It was probably the most marking moment of my stay as […]How could I build a flying bicycle?
+
2:43 PM | DNA Reveals the Identity of Jack the Ripper?
In the late 1800s, Victorian England was mesmerized and horrified by a series of brutal killings in the crowded and impoverished Whitechapel district. The serial killer, who became known as “Jack the Ripper”, had murdered and mutilated at least five women, many of whom worked as prostitutes in the slums around London. None of these […]
+
1:37 PM | Merck Serono pulls development of lung cancer prospect
Ditches tecemotide immunotherapy to focus on anti-PD1
+
1:18 PM | Friday SNPpets
Welcome to our Friday feature link collection: SNPpets. During the week we come across a lot of links and reads that we think are interesting, but don’t make it to a blog post. Here they are for your enjoyment… RT @wejlab: Our PathoScope 2.0 paper is now published online! http://t.co/1wn0fCzgJK @BU_CBM @BUbioinfo RT @rnomics: Pegasus: […]
+
12:33 PM | Right Turn: Super Cells takes flight
> Those of you who’ve been following this blog regularly will know that we were in the process of building a science exhibit — we’ve published a few teasers, here and here. This week, Super Cells: The power of stem cells was unveiled in the small, historic city of Sherbrooke, Québec (well worth a visit,...Read more
+
10:50 AM | FDA panel backs Novo Nordisk's liraglutide for obesity
Committee says diabetes drug could be used to reduce weight
+
10:25 AM | AbbVie-partnered Calico unveils first licensing deal
Google’s healthcare research business gains rights to drug prospects in neurodegeneration
+
9:26 AM | Pre-chemotherapy indication for Xtandi in prostate cancer
Astellas drug set to compete with J&J’s Zytiga
+
8:55 AM | C. Elegans Rap!
Tweet This Post

September 11, 2014

+
11:15 PM | Gopa Mitra retires from PAGB
She steps down after 34 years at organisation
+
11:07 PM | Mumps vaccine effectiveness and waning immunity
In a previous article, from our vaccine legal expert, Dorit Reiss, we learned that there’s a whistleblower lawsuit against Merck regarding the possibility that the company may have engaged in some inappropriate actions in determining the effectiveness of the MMR vaccine (for mumps, measles and rubella), specifically the mumps component of the vaccine. As Reiss stated, […]Continue reading «Mumps vaccine effectiveness and waning immunity»
+
11:02 PM | The definition of value
Aligning the thoughts of biopharma and other healthcare stakeholders
+
11:02 PM | Dive in: gaining leadership in a therapeutic area
Gaining long-term leadership in a therapy area can be commercially invaluable
+
9:23 PM | The anniversary of September 11–my personal experience
For a moment, I want to step away from my typically snarky commentary about things I see in the pseudoscience world. I want to talk about my own experiences on that day, which, in retrospect, ended up being a closer call than I ever wish to have. You see, on September 11, 2001, I was […]Continue reading «The anniversary of September 11–my personal experience»
+
5:06 PM | FDA Issues Home Use Medical Device Guidance
The FDA has issued a new guidance document intended to clarify how medical device manufacturers should approach certain design decisions for products targeted for home use. ‘Design Considerations For Devices Intended for Home Use’ is the final version of the draft guidance initially published in early 2013, and while it does not add any new ... continue reading
+
4:31 PM | Mylan buys US rights to blood clot drug
$300m deal to acquire Arixtra from South Africa’s Aspen
+
2:02 PM | Second time lucky for Takeda’s obesity drug
FDA approves Contrave three years after initial rejection
+
1:50 PM | Baxter names biopharma spin-off Baxalta
Will separate from medical technology business
+
1:48 PM | Black Pee Disease Offers New View of Arthritic Joints
“A new cause of osteoarthritis identified by research on a rare disease,” ran the headline of a news release a few weeks ago. I was drawn to “rare disease,” even though I actually have osteoarthritis. When I read “alkaptonuria,” I was catapulted back more than a century to the first description of an “inborn error of metabolism.” The release announced a paper in the October Journal of Anatomy, which is behind a paywall.… […]
34567891011
309 Results